Skip to main content

The Dermatologist

Featured

MDT Panel Thumbnail
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
In this closing discussion, faculty share practical recommendations for strengthening multidisciplinary care in high-risk CSCC, emphasizing timely communication, collaboration across specialties, and continuity of care in both academic and...
In this closing discussion, faculty share practical recommendations for strengthening multidisciplinary care in high-risk CSCC, emphasizing timely communication, collaboration across specialties, and continuity of care in both academic and...
In this closing discussion,...
11/18/2026
The Dermatologist
Video 3 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
Through a case involving recurrent scalp CSCC and cognitive impairment, faculty explore how recurrence risk, treatment feasibility, patient preferences, and caregiver involvement influence decisions about surgery, radiation, and adjuvant...
Through a case involving recurrent scalp CSCC and cognitive impairment, faculty explore how recurrence risk, treatment feasibility, patient preferences, and caregiver involvement influence decisions about surgery, radiation, and adjuvant...
Through a case involving...
11/18/2026
The Dermatologist
Video 2 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
The panel discusses a patient with high-risk CSCC, exploring how disease characteristics, immune status, and multidisciplinary input inform postoperative treatment decisions and consideration of adjuvant immunotherapy.
The panel discusses a patient with high-risk CSCC, exploring how disease characteristics, immune status, and multidisciplinary input inform postoperative treatment decisions and consideration of adjuvant immunotherapy.
The panel discusses a patient...
11/18/2026
The Dermatologist
Video 1 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
In this case-based discussion, a multidisciplinary panel examines recurrent high-risk CSCC, including the distinction between local recurrence and in-transit disease, considerations for additional surgery and radiation, and the role of...
In this case-based discussion, a multidisciplinary panel examines recurrent high-risk CSCC, including the distinction between local recurrence and in-transit disease, considerations for additional surgery and radiation, and the role of...
In this case-based discussion, a...
11/18/2026
The Dermatologist
Dean berman
Videos
11/17/2026
Dr Dean Berman discusses the proposed HHS policy on compounded peptides, including BPC-157, KPV, and TB-500, and their potential applications in dermatology.
Dr Dean Berman discusses the proposed HHS policy on compounded peptides, including BPC-157, KPV, and TB-500, and their potential applications in dermatology.
Dr Dean Berman discusses the...
11/17/2026
The Dermatologist
Quiz
Quiz
11/16/2026
Riya Gandhi, MA
Challenge your clinical reasoning in managing prurigo nodularis through targeted therapies, treatment sequencing, and interpretation of variable therapeutic responses.
Challenge your clinical reasoning in managing prurigo nodularis through targeted therapies, treatment sequencing, and interpretation of variable therapeutic responses.
Challenge your clinical...
11/16/2026
The Dermatologist
Jacob
Videos
11/16/2026
Carolyn Jacob, MD; Riya Gandhi, MA
Dr Carolyn Jacob discusses emerging therapies that are expanding hair restoration beyond traditional treatments like minoxidil and finasteride.
Dr Carolyn Jacob discusses emerging therapies that are expanding hair restoration beyond traditional treatments like minoxidil and finasteride.
Dr Carolyn Jacob discusses...
11/16/2026
The Dermatologist
Dr Aaron Farberg
Videos
11/11/2026
Aaron S. Farberg, MD; Jessica Garlewicz
Aaron Farberg, MD, discusses how emerging genomic tools, including the AdvanceAD-Tx test, may help identify distinct molecular profiles in patients with atopic dermatitis and guide more personalized treatment selection.
Aaron Farberg, MD, discusses how emerging genomic tools, including the AdvanceAD-Tx test, may help identify distinct molecular profiles in patients with atopic dermatitis and guide more personalized treatment selection.
Aaron Farberg, MD, discusses how...
11/11/2026
The Dermatologist
Quiz
Quiz
11/09/2026
Riya Gandhi, MA
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the...
11/09/2026
The Dermatologist
Goldberg
Videos
11/09/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how...
11/09/2026
The Dermatologist
Psoriasis on hand
News
11/03/2026
Jessica Garlewicz
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian...
11/03/2026
The Dermatologist

From The Issue

Derm Dx
10/02/2026
Lanah Almatroud, BA; Rania Djemil, BS; Amor Khachemoune, MD, FAAD, FACMS
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran, living in a trailer, sought dermatologic evaluation for new skin lesions appearing on his face and neck.
A 75-year-old male veteran,...
10/02/2026
The Dermatologist
Clinical Tips
10/02/2026
Benjamin Barankin, MD, FRCPC; Ronald Vender, MD, FRCPC; Susan Poelman, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
10/02/2026
The Dermatologist
Cover Story
10/02/2026
Ayman Grada, MD, MHA; Riya Gandhi, MA
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his perspective on how dermatologists can bring clinical insight and scientific expertise to biopharma while keeping patient care at the center of their work.
Dr Ayman Grada shares his...
10/02/2026
The Dermatologist
Cover Story
09/03/2026
Daniel M. Siegel, MD, MS, FAAD, FACMS; Riya Gandhi, MA
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness emerging technologies to improve efficiency and patient care while navigating the challenges of privacy, regulation, medicolegal risk, and information overload?
How can clinicians harness...
09/03/2026
The Dermatologist
Feature Story
09/03/2026
Jennifer Cao, MD; Riya Gandhi, MA
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular cicatricial pemphigoid to SJS/TEN and hydroxychloroquine toxicity, learn what to recognize to help prevent irreversible vision loss through timely referral and multidisciplinary care.
From uveitis and ocular...
09/03/2026
The Dermatologist
Derm Dx
09/03/2026
Sümeyye Aktaş, MD; Mehmet Ali Demirci, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented with a several-year history of progressive color change on the neck.
A 60-year-old woman presented...
09/03/2026
The Dermatologist
Clinical Tips
09/03/2026
Benjamin Barankin, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
09/03/2026
The Dermatologist
Feature Story
08/04/2026
Julia Ross, MD; Noah A. Levit, MD, PhD, FAAD
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the evolving landscape of nonsteroidal topical therapies for atopic dermatitis and chronic hand eczema, with a specific focus on how vehicle formulation and excipient selection may influence clinical performance beyond...
This article examines the...
08/04/2026
The Dermatologist
Derm Dx
08/04/2026
Tanya Henry, MD; Amor Khachemoune, MD, FAAD, FACMS
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American woman presented to the clinic with multiple hyperpigmented, raised papules distributed across the face and neck.
A 60-year-old African American...
08/04/2026
The Dermatologist
Clinical Tips
08/04/2026
Benjamin Barankin, MD, FRCPC
Keep these tips in mind for your next appointment!
Keep these tips in mind for your next appointment!
Keep these tips in mind for your...
08/04/2026
The Dermatologist

Multimedia

MDT Panel Thumbnail
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
In this closing discussion, faculty share practical recommendations for strengthening multidisciplinary care in high-risk CSCC, emphasizing timely communication, collaboration across specialties, and continuity of care in both academic and...
In this closing discussion, faculty share practical recommendations for strengthening multidisciplinary care in high-risk CSCC, emphasizing timely communication, collaboration across specialties, and continuity of care in both academic and...
In this closing discussion,...
11/18/2026
The Dermatologist
Video 3 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
Through a case involving recurrent scalp CSCC and cognitive impairment, faculty explore how recurrence risk, treatment feasibility, patient preferences, and caregiver involvement influence decisions about surgery, radiation, and adjuvant...
Through a case involving recurrent scalp CSCC and cognitive impairment, faculty explore how recurrence risk, treatment feasibility, patient preferences, and caregiver involvement influence decisions about surgery, radiation, and adjuvant...
Through a case involving...
11/18/2026
The Dermatologist
Video 2 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
The panel discusses a patient with high-risk CSCC, exploring how disease characteristics, immune status, and multidisciplinary input inform postoperative treatment decisions and consideration of adjuvant immunotherapy.
The panel discusses a patient with high-risk CSCC, exploring how disease characteristics, immune status, and multidisciplinary input inform postoperative treatment decisions and consideration of adjuvant immunotherapy.
The panel discusses a patient...
11/18/2026
The Dermatologist
Video 1 thumbnail image
Videos
11/18/2026
Stan Tolkachjov, MD, FAAD, FACMS; Mehran Yusuf, MD; Sunandana Chandra, MD; Kevin Emerick, MD
In this case-based discussion, a multidisciplinary panel examines recurrent high-risk CSCC, including the distinction between local recurrence and in-transit disease, considerations for additional surgery and radiation, and the role of...
In this case-based discussion, a multidisciplinary panel examines recurrent high-risk CSCC, including the distinction between local recurrence and in-transit disease, considerations for additional surgery and radiation, and the role of...
In this case-based discussion, a...
11/18/2026
The Dermatologist
Dean berman
Videos
11/17/2026
Dr Dean Berman discusses the proposed HHS policy on compounded peptides, including BPC-157, KPV, and TB-500, and their potential applications in dermatology.
Dr Dean Berman discusses the proposed HHS policy on compounded peptides, including BPC-157, KPV, and TB-500, and their potential applications in dermatology.
Dr Dean Berman discusses the...
11/17/2026
The Dermatologist
Jacob
Videos
11/16/2026
Carolyn Jacob, MD; Riya Gandhi, MA
Dr Carolyn Jacob discusses emerging therapies that are expanding hair restoration beyond traditional treatments like minoxidil and finasteride.
Dr Carolyn Jacob discusses emerging therapies that are expanding hair restoration beyond traditional treatments like minoxidil and finasteride.
Dr Carolyn Jacob discusses...
11/16/2026
The Dermatologist
Dr Aaron Farberg
Videos
11/11/2026
Aaron S. Farberg, MD; Jessica Garlewicz
Aaron Farberg, MD, discusses how emerging genomic tools, including the AdvanceAD-Tx test, may help identify distinct molecular profiles in patients with atopic dermatitis and guide more personalized treatment selection.
Aaron Farberg, MD, discusses how emerging genomic tools, including the AdvanceAD-Tx test, may help identify distinct molecular profiles in patients with atopic dermatitis and guide more personalized treatment selection.
Aaron Farberg, MD, discusses how...
11/11/2026
The Dermatologist
Goldberg
Videos
11/09/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how...
11/09/2026
The Dermatologist
Dr Lisa Swanson
Videos
11/03/2026
Elizabeth Swanson, MD; Jessica Garlewicz
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing atopic comorbidity.
Lisa Swanson, MD, emphasizes the importance of early, effective treatment of pediatric atopic dermatitis, highlighting emerging evidence that dupilumab may improve growth and bone health outcomes while potentially reducing atopic comorbidity.
Lisa Swanson, MD, emphasizes the...
11/03/2026
The Dermatologist
type 2 KOL roundtable part 1
Videos
11/02/2026
Raj Chovatiya, MD, PhD; Tina Bhutani, MD, MAS; Daniel C. Butler, MD; Jason Ezra Hawkes, MD, MS, FAAD
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases,.
Dr Raj Chovatiya moderates an expert roundtable with Drs Tina Bhutani, Daniel Butler, and Jason Hawkes, exploring how type 2 inflammation drives chronic inflammatory skin diseases,.
Dr Raj Chovatiya moderates an...
11/02/2026
The Dermatologist

Partner Reviewed

NEA Approved Features
10/02/2026
Coleen Stern, MA
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the National Eczema Association outlines its comprehensive State of AD Indicator Report, providing a foundation for targeted action nationwide.
In this 2-part series, the...
10/02/2026
The Dermatologist
HSF-Reviewed Content
09/03/2026
Andre Hall, BA; Colleen Cotton, MD
The treatment landscape for adolescents with moderate-to-severe disease has changed considerably over the past few years.
The treatment landscape for adolescents with moderate-to-severe disease has changed considerably over the past few years.
The treatment landscape for...
09/03/2026
The Dermatologist
HSF-Reviewed Content
06/08/2026
Leandra A. Barnes, MD, FAAD; Jessica Garlewicz
A developing pipeline is shifting care toward individualized, multi-pathway approaches while highlighting ongoing gaps in treatment expectations and patient access.
A developing pipeline is shifting care toward individualized, multi-pathway approaches while highlighting ongoing gaps in treatment expectations and patient access.
A developing pipeline is...
06/08/2026
The Dermatologist
NRS Approved Features
05/25/2026
Eden Robins
Hormonal fluctuations, hot flashes, and skin barrier changes during this stage of life may trigger rosacea onset or worsen existing symptoms.
Hormonal fluctuations, hot flashes, and skin barrier changes during this stage of life may trigger rosacea onset or worsen existing symptoms.
Hormonal fluctuations, hot...
05/25/2026
The Dermatologist
NRS Approved Features
05/24/2026
Andrew Huff
This disease subtype is often difficult to treat, with patients reporting minimal or no improvement in signs and symptoms with standard therapies.
This disease subtype is often difficult to treat, with patients reporting minimal or no improvement in signs and symptoms with standard therapies.
This disease subtype is often...
05/24/2026
The Dermatologist
NEA Approved Features
05/21/2026
Coleen Stern, MA
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key aspects of eczema, from the science and genetics behind inflammation to advanced screening and patient-reported outcomes.
New research will explore key...
05/21/2026
The Dermatologist
NRS Approved Features
04/06/2026
Eden Robins
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the potential of using artificial intelligence models to diagnose dermatologic conditions while noting that the current state of these tools may lead to misdiagnosis, inaccurate information, and inaccessible language.
Recent studies point to the...
04/06/2026
The Dermatologist
HSF-Reviewed Content
03/09/2026
Mondana Ghias, MD, FAAD
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach, care teams can achieve greater clarity, stability, and long-term disease control.
Through a longitudinal approach,...
03/09/2026
The Dermatologist
NEA Approved Features
03/09/2026
Allison Loiselle, PhD; Jessica Garlewicz
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association offers practical guidance on assessing transition readiness and empowering adolescents and young adults as they move toward independent atopic dermatitis care.
The National Eczema Association...
03/09/2026
The Dermatologist
NRS Approved Features
01/30/2026
Andrew Huff
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may contribute to the development of this chronic skin condition.
Imbalances in the mycobiome may...
01/30/2026
The Dermatologist

News and FDA Alerts

Psoriasis on hand
News
11/03/2026
Jessica Garlewicz
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian dermatologists proposed practical criteria for defining moderate psoriasis, emphasizing the importance of combining objective severity measures with patient-reported outcomes to improve treatment selection and reduce...
A panel of Italian...
11/03/2026
The Dermatologist
Physician talk with overweight man
News
11/03/2026
Jessica Garlewicz
Psoriasis and obesity share inflammatory pathways that may contribute to greater disease severity, reduced treatment response, and increased metabolic complications.
Psoriasis and obesity share inflammatory pathways that may contribute to greater disease severity, reduced treatment response, and increased metabolic complications.
Psoriasis and obesity share...
11/03/2026
The Dermatologist
Scientist in lab
News
11/03/2026
Jessica Garlewicz
Advances in single-cell RNA sequencing and spatial transcriptomics are reshaping understanding of psoriasis pathogenesis, highlighting the role of cellular interactions and tissue microenvironments in disease heterogeneity.
Advances in single-cell RNA sequencing and spatial transcriptomics are reshaping understanding of psoriasis pathogenesis, highlighting the role of cellular interactions and tissue microenvironments in disease heterogeneity.
Advances in single-cell RNA...
11/03/2026
The Dermatologist
Psoriasis on foot
News
11/03/2026
Jessica Garlewicz
Patients exhibiting overlapping features of psoriasis and atopic dermatitis may present distinct diagnostic and therapeutic challenges due to mixed inflammatory pathways.
Patients exhibiting overlapping features of psoriasis and atopic dermatitis may present distinct diagnostic and therapeutic challenges due to mixed inflammatory pathways.
Patients exhibiting overlapping...
11/03/2026
The Dermatologist
Physician with dermatoscope
News
11/03/2026
Jessica Garlewicz
Dermoscopy combined with ultraviolet imaging may help distinguish early-stage mycosis fungoides, psoriasis, and atopic dermatitis.
Dermoscopy combined with ultraviolet imaging may help distinguish early-stage mycosis fungoides, psoriasis, and atopic dermatitis.
Dermoscopy combined with...
11/03/2026
The Dermatologist
Atopic dermatitis
News
11/03/2026
Jessica Garlewicz
Emerging immunoassay-based biomarkers may improve disease assessment and support personalized treatment strategies for patients with atopic dermatitis.
Emerging immunoassay-based biomarkers may improve disease assessment and support personalized treatment strategies for patients with atopic dermatitis.
Emerging immunoassay-based...
11/03/2026
The Dermatologist
Two doctors in a lab
News
11/03/2026
Jessica Garlewicz
Salivary biomarkers may provide a noninvasive approach to monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
Salivary biomarkers may provide a noninvasive approach to monitoring stress, sleep quality, and disease severity in patients with atopic dermatitis.
Salivary biomarkers may provide...
11/03/2026
The Dermatologist
News
11/03/2026
Jessica Garlewicz
Dupilumab treatment was associated with improvements in height growth and bone mineralization markers among children with severe atopic dermatitis.
Dupilumab treatment was associated with improvements in height growth and bone mineralization markers among children with severe atopic dermatitis.
Dupilumab treatment was...
11/03/2026
The Dermatologist
diet
News
11/02/2026
Coleen Stern, MA
Diet may represent a modifiable factor in skin barrier integrity and atopic dermatitis, but inconsistent findings prevent definitive dietary recommendations.
Diet may represent a modifiable factor in skin barrier integrity and atopic dermatitis, but inconsistent findings prevent definitive dietary recommendations.
Diet may represent a modifiable...
11/02/2026
The Dermatologist
Collagen and vitamin drop skin cell
News
10/29/2026
Coleen Stern, MA
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and Human Services has outlined an interim enforcement policy for compounding 6 peptide bulk drug substances while their inclusion on the section 503A bulks list is considered through rulemaking.
The US Department of Health and...
10/29/2026
The Dermatologist

Quizzes

Quiz
Quiz
11/16/2026
Riya Gandhi, MA
Challenge your clinical reasoning in managing prurigo nodularis through targeted therapies, treatment sequencing, and interpretation of variable therapeutic responses.
Challenge your clinical reasoning in managing prurigo nodularis through targeted therapies, treatment sequencing, and interpretation of variable therapeutic responses.
Challenge your clinical...
11/16/2026
The Dermatologist
Quiz
Quiz
11/09/2026
Riya Gandhi, MA
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the...
11/09/2026
The Dermatologist
Physician with child
Quiz
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist

Professional Development

Conference Coverage

Goldberg
Videos
11/09/2026
David Goldberg, MD, JD; Riya Gandhi, MA
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how dermatologists can safely use energy-based devices in patients with skin of color while minimizing risks such as hyperpigmentation, hypopigmentation, and burns.
Dr David Goldberg discusses how...
11/09/2026
The Dermatologist
Raj Chovatiya, MD, PhD
Conference Coverage
10/09/2026
Jessica Garlewicz
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026 Fall Clinical Dermatology Conference, Raj Chovatiya, MD, PhD, discussed key considerations for individualizing biologic therapy in moderate-to-severe AD.
Ahead of his session at the 2026...
10/09/2026
The Dermatologist
Lisa Swanson
Conference Coverage
10/09/2026
Jessica Garlewicz
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical Dermatology Conference, Lisa Swanson, MD, emphasized that decisions to escalate treatment for moderate-to-severe atopic dermatitis should consider both clinical disease severity and the patient’s experience.
Prior to the 2026 Fall Clinical...
10/09/2026
The Dermatologist
Lain
Videos
05/27/2026
Ted Lain, MD; Riya Gandhi, MA
Dr Ted Lain discusses the emerging role of gut health in rosacea, including the link between small intestinal bacterial overgrowth (SIBO) and treatment-resistant disease.
Dr Ted Lain discusses the emerging role of gut health in rosacea, including the link between small intestinal bacterial overgrowth (SIBO) and treatment-resistant disease.
Dr Ted Lain discusses the...
05/27/2026
The Dermatologist
Baldwin
Videos
05/22/2026
Hilary E. Baldwin, MD; Riya Gandhi, MA
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how evolving insights into the skin microbiome are reshaping the understanding of acne, eczema, rosacea, and other inflammatory skin diseases.
Dr Hilary Baldwin discusses how...
05/22/2026
The Dermatologist
clark
Videos
05/22/2026
Patrick J. Clark, PhD; Riya Gandhi, MA
Patrick Clark, PhD, CMLSO, reviews the foundational principles behind safe and effective use of energy-based devices in dermatology, including wavelength, pulse duration, power, spot size, and target chromophore selection.
Patrick Clark, PhD, CMLSO, reviews the foundational principles behind safe and effective use of energy-based devices in dermatology, including wavelength, pulse duration, power, spot size, and target chromophore selection.
Patrick Clark, PhD, CMLSO,...
05/22/2026
The Dermatologist
Mesinkovska
Videos
05/20/2026
Natasha Atanaskova Mesinkovska, MD, PhD; Riya Gandhi, MA
Dr Natasha Mesinkovska explores how metformin and GLP-1 receptor agonists may influence skin aging, pigmentation, wound healing, and longevity pathways.
Dr Natasha Mesinkovska explores how metformin and GLP-1 receptor agonists may influence skin aging, pigmentation, wound healing, and longevity pathways.
Dr Natasha Mesinkovska explores...
05/20/2026
The Dermatologist
Kaufmann
Conference Coverage
05/20/2026
Jessica Garlewicz
The buy-and-bill reimbursement model may provide dermatology practices with greater control over treatment delivery, faster patient access to therapy, and potential operational advantages.
The buy-and-bill reimbursement model may provide dermatology practices with greater control over treatment delivery, faster patient access to therapy, and potential operational advantages.
The buy-and-bill reimbursement...
05/20/2026
The Dermatologist
Shamban
Conference Coverage
05/20/2026
Jessica Garlewicz
Scalable systems, proactive patient engagement, and integrated treatment strategies may strengthen both clinical outcomes and operational resilience in dermatology practices.
Scalable systems, proactive patient engagement, and integrated treatment strategies may strengthen both clinical outcomes and operational resilience in dermatology practices.
Scalable systems, proactive...
05/20/2026
The Dermatologist
Marmur
Conference Coverage
05/20/2026
Jessica Garlewicz
Selling a dermatology practice requires long-term planning, financial analysis, and careful alignment between physicians, staff, and investors.
Selling a dermatology practice requires long-term planning, financial analysis, and careful alignment between physicians, staff, and investors.
Selling a dermatology practice...
05/20/2026
The Dermatologist